Noxopharm Limited

ASX:NOX.AX

0.1 (AUD) • At close September 16, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q32017 Q22016 Q42016 Q32016 Q2
Omzet 01.2122.6643.3463.641.7894.2531.3554.523.7620.4863.2640.0610.8560.12600000
Kosten van de omzet 0.0010.0010.0110.1430.130.1320.1310.1310.1290.1130.031000000000
Brutowinst -0.0011.2112.6533.2023.511.6574.1221.2244.3913.6490.4553.2640.0610.8560.12600000
Brutowinstmarge 00.9990.9960.9570.9640.9260.9690.9040.9720.970.936111100000
Onderzoek- en ontwikkelingskosten 1.4841.4514.8525.7954.6973.0815.2223.0473.7813.5523.4322.8191.8782.2350.5800.236000
Algemene en administratieve kosten 00.5210.5770.90.7420.9220.8380.7560.542.5051.2371.4961.0120.7770.5450.420.41000
Verkoop- en marketingkosten 01.4980.1922.1270.1042.3990.1293.5262.1723.5750.023.1460.0531.8530.1070.0270.027000
Verkoop-, algemene en administratieve kosten 2.0462.0192.7643.0273.8473.3213.0984.2812.7136.084.7114.6433.6992.631.4760.4470.906000
Overige kosten 00000000000000-0.091-0.091-0.091000
Bedrijfskosten 3.533.477.6168.8228.5446.4028.327.3286.4939.6328.1447.5136.41812.8822.0720.3561.168000
Bedrijfsresultaat -3.531-3.471-7.627-8.965-8.674-6.534-8.451-7.459-6.622-9.745-8.175-4.228-5.56-4.025-1.943-0.761-1.159000
Bedrijfsresultaat ratio 0-2.864-2.863-2.68-2.383-3.653-1.987-5.504-1.465-2.59-16.809-1.295-91.116-4.704-15.38500000
Totaal overige inkomsten en kosten netto 1.263-0.239-4.6670.218-4.97-3.8576.0470.2569.825-1.695-0.43-0.226-0.77-7.9660.03600.02000
Inkomen voor belasting -2.269-3.71-12.294-8.747-13.644-10.391-2.404-7.2023.203-11.44-8.605-4.454-6.33-11.991-1.907-0.761-1.139000
Inkomen voor belasting ratio 0-3.061-4.614-2.615-3.748-5.809-0.565-5.3150.709-3.041-17.693-1.364-103.743-14.016-15.09800000
Belastingkosten -1.188-1.212-2.664-3.321-3.59-1.7780.221-1.3-4.57-3.762-0.486-0.858-0.0370000000
Nettowinst -1.08-2.498-9.63-5.427-10.054-8.613-2.624-6.7226.678-6.95-6.769-3.596-6.293-11.991-1.907-0.761-1.139000
Nettowinstmarge 0-2.061-3.614-1.622-2.762-4.815-0.617-4.9611.477-1.847-13.918-1.102-103.136-14.016-15.09800000
WPA (Winst Per Aandeel) -0.004-0.009-0.033-0.019-0.034-0.03-0.009-0.0310.031-0.05-0.049-0.03-0.055-0.12-0.022-0.009-0.016000
Verwaterde WPA -0.004-0.009-0.033-0.019-0.034-0.03-0.009-0.0310.031-0.05-0.049-0.03-0.055-0.12-0.022-0.009-0.016000
EBITDA -3.53-3.47-7.616-8.822-8.544-6.402-8.32-7.328-6.493-9.632-8.144-4.197-5.516-4.009-1.942-0.754-1.142000
EBITDA ratio 0-2.863-2.858-2.637-2.347-3.579-1.956-5.408-1.437-2.56-16.745-1.286-90.406-4.686-15.37400000